Montréal, Canada, April 5th, 2010. Bio-Solutions Corp. (BISU: OTCBB), is pleased to address shareholders and investing public regarding the company.

At Bio-Solutions Corp, we market, solicit, and encourage, the use of our flagship FDA approved Organic Malaria Insecticide; GreenEx™.

Leading up to the past 6 months, we at Bio-Solutions Corp, have been working extremely hard to be the greenest most environmentally friendly company we can build. We have been in between our Home base of Montreal, and Africa.

To recap out achievement in the past few months:

-        The Addition of Dr. Max Arella to our Advisory committee. “Dr Arella is the Brainchild behind GreenEx™, our flagship product.  We are quite honoured, to add such an influential person, to our committee.”states CEO and President Gilles Chaumillon.

-        The Addition of Mr. Diallo, to Bio-Solution's Corp Advisory committee. "Mr Diallo has an extensive knowledge of numerous African countries and he will help us refine our market penetration strategy to adjust to the situation in each country" states Dr Chaumillon.  Mr. Diallo has been elected to the National Assembly of Burkina Faso in 2007 and is currently the Fifth Vice-President of the National Assembly. Mr.Diallo was the Executive Secretary of the United Nations (UN) Convention to Combat Desertification from 1996 to 2007. Prior to this, he was the Special Representative of the Secretary General of the UN  Conference on Environment and Development (UNCED) during the preparations for the Rio Summit. He was also in charge of the preparatory process for UNCED in Africa. Previous to his UN activities, Mr. Diallo served 24 years as a top official in the state and foreign ministries of Burkina Faso. In 1983, he became Minister of Foreign Affairs. From 1988 – 89 he served as Ambassador of Burkina Faso to China, India and Japan.

-        We made our African Cable Debut. “We have made quite a splash in Africa, as municipalities are learning how easy our GreenEx™ is to use; the demand is growing for our product. The cable response has been overwhelming. ”states Dr Chaumillon,

-        We received our first LOI, from Burkina Faso for our main product GreenEx™. 

-        We also received our first service agreement in a district of Kinshasa, Democratic Republic of Congo, which has volunteered to run our initial pilot trial there.

-         Our Get to know Clip, featured on  www.ceocfointerviews.com, which is a one on one with Dr. Gilles Chaumillon

http://ceocfointerviews.com/interviews/BISU-BioSolutions10.htm

For more information on Bio-Solutions Corp. and its products, please visit the company's website at www.bio-solutionscorp.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbour provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions’ actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of studies, the ability of the Company to take advantage of business opportunities in the biotechnology industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company’s quarterly and annual filings with the U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.

Contacts Investor & Public Relations

Jakub Hryniewicz

(708) 829-4585